Anterix Inc.·4

Jun 17, 7:07 PM ET

Lang Scott A. 4

4 · Anterix Inc. · Filed Jun 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Anterix (ATEX) CEO Scott A. Lang Exercises Stock Options

What Happened

  • Scott A. Lang, President, CEO and Director of Anterix (ATEX), exercised two stock option tranches on June 15, 2026 to acquire a total of 138,318 shares (63,788 and 74,530 shares).
  • Exercise prices were $30.99 and $34.96 (total exercise cost shown as $4,582,359). The company withheld 39,621 and 48,470 shares, respectively, at $82.50/share to cover the exercise price and tax withholding — a withholding value of about $7,267,508. After withholding, Lang received a net of 50,227 shares.

Key Details

  • Transaction date: 2026-06-15; Form filed 2026-06-17 (filed within the typical two-business-day Form 4 window).
  • Action codes: M = option exercise (acquired 63,788 @ $30.99 and 74,530 @ $34.96); F = withholding to pay exercise price/taxes (39,621 and 48,470 shares withheld at $82.50).
  • Net shares received by insider after withholding: 50,227 shares.
  • Footnotes clarify the exercise was cashless and the withheld shares were used to pay exercise price and tax obligations; the withholding did not involve an open-market sale.
  • Vesting: the option grants vest over three annual installments (vesting commencement and schedule referenced in the filing footnotes).

Context

  • This was an exercise of vested options with a cashless settlement (company withheld shares rather than the insider paying cash or selling shares in the open market). Cashless exercises plus withholding for taxes are common and do not necessarily indicate a buy/sell market signal.
  • The filing does not show the insider’s total holdings after the transaction in this summary; refer to the full Form 4 for the reported ownership balance.

Insider Transaction Report

Form 4
Period: 2026-06-15
Lang Scott A.
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-15$30.99/sh+63,788$1,976,79090,258 total
  • Exercise/Conversion

    Common Stock

    2026-06-15$34.96/sh+74,530$2,605,569164,788 total
  • Tax Payment

    Common Stock

    [F1]
    2026-06-15$82.50/sh39,621$3,268,733125,167 total
  • Tax Payment

    Common Stock

    [F2]
    2026-06-15$82.50/sh48,470$3,998,77576,697 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-06-1563,788127,538 total
    Exercise: $30.99Exp: 2035-01-17Common Stock (63,788 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-06-1574,530149,016 total
    Exercise: $34.96Exp: 2035-05-21Common Stock (74,530 underlying)
Footnotes (4)
  • [F1]The Reporting Person exercised a stock option to purchase 63,788 shares of the Issuer's Common Stock for $30.99 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 39,621 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
  • [F2]The Reporting Person exercised a stock option to purchase 74,530 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 48,470 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
  • [F3]3. The shares subject to the option shall vest and become exercisable in three annual installments with vesting commencing on January 17, 2025, subject to the Reporting Person's continuous services to the Issuer through each such vesting date.
  • [F4]The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 21, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter.
Signature
/s/ Gena L. Ashe|2026-06-17

Documents

1 file
  • 4
    wk-form4_1781737632.xmlPrimary

    FORM 4